A multicenter phase II study of docosahexaenoic acid (DHA) in patients (pts) with a history of breast cancer (BC), premalignant lesions, or benign breast disease Meeting Abstract


Authors: Gucalp, A.; Morris, P. G.; Zhou, X. K.; Giri, D. D.; Iyengar, N. M.; Crew, K. D.; Hershman, D. L.; Garber, J. E.; Nangla, J. R.; Cook, E. D.; Vornik, L.; Dunn, B. K.; Heckman-Stoddard, B. M.; Foster, K.; Brown, P.; Dannenberg, A.; Hudis, C. A.
Abstract Title: A multicenter phase II study of docosahexaenoic acid (DHA) in patients (pts) with a history of breast cancer (BC), premalignant lesions, or benign breast disease
Meeting Title: 50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 15 Suppl.
Meeting Dates: 2014 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-05-20
Language: English
ACCESSION: WOS:000358613202013
PROVIDER: wos
DOI: 10.1200/jco.2014.32.15_suppl.tps1615
Notes: Meeting Abstract; TPS1615 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Patrick Glyn Morris
    116 Morris
  2. Clifford Hudis
    905 Hudis
  3. Dilip D Giri
    184 Giri
  4. Ayca Gucalp
    113 Gucalp
  5. Neil Mukund Iyengar
    150 Iyengar
Related MSK Work